|
|
|
|
|
|
Ingredients
Important intestional bacteria for humans include:
•Lactobacillus rhamnosus
•Bibidobacterium bifidum
•Lactobacillus acidophilus
•Bifidobacterium infantis
•Bifidobacterium longum
•Strereptococcus thermophilus
•Lactobacillus plantarum
•Lactobacillus salivarius
•Lactobacillus reuteri
•Lactobacillus casei
•Lactobacillus bulgaricus
•Lactobacillus acidophilus DDS-1
•Lactobacillus sporogenes
Lactobacillus Rhamnosus:
A normal inhabitant of the vaginal and digestive tract in humans and
animals. Lactobicillus rhamnosus has demonstrated immune
enhancing qualities of special interest.
Dietary intake of Lactobicillus rhamnosus can be
especially beneficial for infants and for the elderly.
This species of lactobacilli has been found to quickly colonize, acidify and
protect the small and large intestine against toxins, while creating the
anaerobic conditions that are conducive to the beneficial implantation of
bifidobacteria.
Administration of the lactic bacteria is being used on a large scale for
the prevention or inhibition of uropathogenic bacteria, with studies being
conducted on the use of L. rhamnosus in reguards to the
prevention of recurrent urinary tract infections.
“Bacillus doderlein” has, for decades, been identified or designed as
the species of bifidobacterium and lactobacilli that comprise normal vaginal
flora. L. rhamnosus and L. acidophilus are among a number of
lactobacilli that have been identified in this category. These indigenous
vaginal lactic flora inhibit the growth of uropathogens, such as:
• Candida albicans
• escherichia coli
• hemophilus vaginalis
• trichomonas vaginalis
L. Rhamnous may be considered as one of the more important
lactobacilli—it has been shown, for example, to have many advantages
over L .acidophilus, including:
1. Digestion of a greater number of carbohydrates.
2. More resistance to bile salts, thus insuring its survival during the
process of digestion.
3. Better survival to freeze-drying and a longer shelf life.
According to noted Canadian bacteriologist, Edward Brochu, L
rhamnosus exhibits a number of fascinating immunological properties.
For example, in animal studies it has been demonstrated to increase the
natural killing activity of spleen cells, which may help to prevent tumor
formation.
It also demonstrated an increased resistance to listeria
monocytogenes—the disease causing bacteria associated with encephalitis. Even
more laboratory studies have shown L rhamnosus to boost
phagocytic activity (i.e., the destruction of foreign invaders and other
harmful matter by phagocytes) by three times normal activity. Circulating
antibodies have been shown to increase by six to eight times their normal
levels after introduction of L. rhamnosus.
L. rhamnosus may also help the body resist microbial
infections by increasing levels of immunoglobulins and directly activating
macrophages. Researcher Brochu, of the Institute of Rosell of Montreal,
Canada, concludes one report by saying: “l. rahmnosus may
be considered as one of the most important lactobacilli, if not the best.”.
Lactobacillus rhamnosus produces L(+) lactic acid,
which is biologically superior toDL lactic acid produced by l. acidophilus.
Bifidobacteria
Found through out the intestinal tract, including the mouth and vaginal
tract of humans, as well as the gastrointestinal tract of animals—
bifidobacteria constitute a major part of the fecal flora of healthy
humans.
Bifidobacteria consist of a number of different species,
four of the most important being:
B. longum
B. bifidum
B.infantis
B. breve
From birth these vital bifidobacteria play a
crucial role in human health. When a baby is born, the
intestines are virtually sterile, free of microorganisms. Immediately,
something like a wild west show land grab ensues as friendly and harmfu acetic
and bacteria alike vie for territory and dominance. Between the fourth and
seventh day among breast-fed babies, bifidobacteria normally
outdo the rest of the fields. Researchers now realize that one of the chief
reasons breast-fed babies get markedly fewer infections than formula-fed
babies is that mother’s milk tends to promote superior growth of
bifidobacteria in the gastrointestinal tract, whereas non-breast milk,
infant formulas have little such beneficial effect.
These highly beneficial bifidobacteria are the predominant
organisms in the stools of breast-fed infants, and account for about 99% of
the micro-flora in the large intestine and a lesser amount in the lower part
of the small intestine. In adolescents and adults, bifidobacteria should
constitute a major part of the large intestine’s micro-flora. These
microorganisms produce high degrees of essential by-products in the
intestines, which act as a barrier to the growth of dangerous pathogenic
microbes that can cause infection and disease and they can aid in:
• Production of lactic acid, with small amounts of formic acid from
fermentable carbohydrates, which increase and balance the acidity of the large
intestine and lower part of the small intestine—thereby, inhibiting toxic
bacteria and ammonia production from illnesses such as chronic liver disease.
• Inhibition of bacteria which can alter or convert nitrates in the
intestine (derived from food or water) into potentially harmful nitrates.
• Alleviation or prevention of intestionall disorders following
antibiotic therapy.
• Dietary management of liver conditions.
• Production of B vitamins and correction of vitamin K defiency.
• Self-cleaning of the intestine—reduction of intestional putrefaction
and control of enteric infection in infants.
• Nutrition, nitrogen retention and weight gain in infants.
• Re-establishment and maintenance of health vaginal flora.
• Beneficial effects in cases of leukemic patients.
Unfortunately, the levels of beneficial bifidobacteria
appear to decline dramatically as the human body ages. Some
researchers believe this steep decline is due chiefly to gradual disruptions
and changes in the acid/alkaline balance of the bowels, which tend to favor
the growth of harmful viral and fungal organisms as well as putrefactive,
disease-causing bacteria and disfavor the growth of beneficial
bifidobacteria.
Many researchers now believe that declining levels of
bifidobacteria in the intestional tract may actually mark the eventual
onset of chronic degenerative disease. These declines brought on by aging make
supplementation with beneficial microorganisms all the more important.
Furthermore, these vital bifidobacteria may help detoxify the
human system and remove numerous harmful substances.
According to David B. Hughes and Dallas G. Hoover of the University of
Delaware, bifidobacteria have the ability to eliminalte
substances which can lead to the development of cancer. Bifidobacteria
may also prevent potential toxicity from nitrates and nitrosamines in food
and can kill or control E. coli, staphyloccus aureus (causes toxic shock
syndrome) and shigella. In addition, they help to recycle estrogen (a female
hormone) which assist in reducing the symptoms of menopause, including
osteoporosis.
Japanese research has recently shown that these beneficial
microorganisms are substantial producers of important B vitamins. the
production of these B vitamins is of special importance today, especially
where a large number of adult Americans lack needed levels of these nutrients.
According to recent medical data, without adequate levels of B
viramins—especiall B-6 and B-12—the human body has a difficult time converting
high levels of the atherosclerosis-promoting compound homocysteine into
harmless cystathionine, which may result in a more rapid onset of hardening of
the arteries. Proper levels of these essential B vitamins may help as a
preventative to arteriosclerosis. It is also of vital necessity to maintain
adequate levels of B-12 in order to sustain peak mental agility and physical
vigor as we age. Many of the problems associated with aging—mental fatigue,
depression, low energy levels, upper respiratory problems, and more—have been
linked to decreasing levels pf B-12.
Some researchers suggest that supplementing the body with a
healthy population of bifidobacteria may be
extremely helpful in maintaining adequate levels of these
important health-enhancing and disease preventing B vitamins.
Bifidobacteria produce favorable L(+)
lactic acid.
Lactobacillus Acidophilus
Well documented and established as a normal, beneficial inhabitant of
the small intestine (lower portion) and large intestine—L.
acidophilus is found in the intestines, mouth and vagina of humans and
in the intestines of animals.
L. acidolphilus is the organism most readily utilized in
intestional bacteria therapy, and is among the species of lactobacilli that
are recognized as effective agents in the protection of the genitourinary
system. The major beneficial functions of L. acidophilus strains
include:
• The promotion of a midly acid reaction which stimulates peristalsis
and a favorable environment for normal metabolism.
• Production of a type of lactic acid, which has a bacteriostatic affect
on many undesirable organisms, including pathogenic candida albicans.
• Production of natural antibiotic substances that are antagonistic to
many toxic enteric organisms.
• Relief of gastrointestional discomfort caused by diarrhea,
constipation, flatulence, colitis, pruritis, enteritis and bloating.
• Adjunct therapy in the relief of thrush, canker sores (herpes
lesions), vaginitis, halitosis and acne.
• Assists in the digestion of nutrients and in the production of
lactase, the enzyme that enhances the digestion of milk sugar (lactose).
• Potential aid in the reduction of undesirable cholesterol levels.
• General protection against an imbalance of the intestinal micro-flora.
Scientists are now discovering even more amazing qualities possessed by
this famous resident microorganism. For example, Dr. Morton Walker, in his
recent book, “Seceret of Long Life”, reports that L.
acidophilus has now been shown to produce, at least, four powerful
anti-microbial compounds, including acidolin, acidolphilin, lactocidin, and
bacteriocin.
Each of these compounds has demonstrated formidable neutralizing effects
against serious disease-causing microbes such as:
• campylobacter
• listeria
• staphylococci
• and a long list of others
Moreover, Eileen Hilton, and infectious disease specialist at the Long
Island Jewish Medical Center in New York, has recently demonstrated the
phenomenal disease-preventing effects of this amazing beneficial microorganism
on women who had previously suffered with chronic vaginal yeast infections.
Ongoing research being conducted by the University of Nebraska and
reported by renowed probiotic expert Dr. Khem Shahani, Professor, Department
of Food Science and Technology, has shown that the powerful DDS-1 strain of L.
acidophilus, known as the “Cadillac” strain, is not only able to reduce
cholesterol levels, but is also able to inhibit the growth and toxin-producing
capabilities of 23 known disease-causing pathogens, as well as reduce tumor
growth and effectively neutralize or inhibit carcinogenic substances in
laboratory studies.
Additionally, according to Professor Shahani, “Selected and specially
grown strains of L. acidolphilus have shown both antifungal and
antiviral activity. Consequently…acidolphilus can retard the proliferation of
vaginitis, as well as flu or herpes.”
Lactobacillus acidophilus produces DL-Lactic acid.
Streptococcus Thermophilis
Streptococcus thermophilis, a bacteria found in
yougart, (unpasturized) is a transient microorganism which also
produces a number of antibiotic-like substances as part of its metabolic
process, aiding the body in its ongoing fight against disease-causing microbes.
Perhaps more importantly, S. thermophilus also helps to
suppress tumor development and growth in laboratory studies. Moreover,
S. thermophilus produces substantial quantities of lactase, the enzyme
that aids in the digestion of milk sugars, which may provide an effective
remedy against lactose intolerance (a condition affecting nearly two-thirds of
the world’s population).
It has also been used in hospitals as an effective remedy for
chronic diarrhea in infants.
Lactobacillus Plantarum
L. Plantarum has an unusual ability to rapidly digest
protein and liquefy gelatin. Japanese researchers reported in the Journal of
Allergy & Clinical Immunology that L. Plantarum has proven
useful for the prevention and treatment of food allergy.
It also performs a key function in the regulation of gut inflammation
and immunity, according to researcher S. Bengmark, M.D., from Lund University
in Lund, Sweden. He further states that L. plantarum has the
ability to preserve vital nutrients such as 3 fatty acids for usage by the
body.
Astronauts returning to earth have a significantly reduced ecoflora in
which L. plantarum is totally eliminated, both in saliva and
stool, accompanied by increased toxic bacteria. These alterations are
attributed to a combination of stress and the fiber-reduced diet consumed by
the astronauts, not unlike the diets of many Americans today.
In another study from Lund University reported in the medical journal
Gastroenterology it was found that L. plantarum decreased
overall pathogenic bacteria counts and actually increased Lactobacillus
population in the GI tract of animals whose intestional micro-flora was
disrupted through the use of chemotherapy, causing “drug induced
enterocolitis”.
The secretion of salivary and GI mucus is often significantly reduced
through disease and the use of pharmaceuticals. L. plantarum,
which has no difficulty in surviving the acidity of the stomach and the
bile-acid content of the small intestine, actually plays an important role in
stimulating gut immunity by colonizing and restoring the intestinal mucosa.
One of the important roles of this mucosal lining is to prevent the GI tract
contents—containing potentially pathogenic microorganisms—from leaking into
the bloodstream.
A study done at the Regional Center for Atherosclerosis Institute,
Pomeranian Academy of Medicine in Szezecon, Poland and reported in the journal
Atherosclerosis, demonstrated that L. plantarum added to the
diets of subjects with moderately elevated cholesterol levels and a decrease
of proteins in the blood which cause thrombosis or embolism was beneifical.
Lactobacillus salivarius
A unique strain of a specialized hypoallergenic super-culture, L.
salivarius is a potent and friendly gastrointestinal flora. L
. salivarius is normally present in the mouth and digestive
tract of humans and hampsters and in the intestinal tract of the hen.
Ingestion of L. salivarius helps to increase energy by
making food nutrients readily available to the body; undigested proteins and
their by-products are broken down, while neutralizing putrefactive pathogens.
L. slaivarius aids in maintaining the homestatisis of the digestive
tract and colon, and in improving the body’s ecological balance. It has been
reported that symptoms of food poisoning have been relieved within 30 to 60
minutes after the ingestion of L. salivarius.
L. salivarius is a gram positive, L(+) lactic acid
producer.
Lactobacillus Casei
(Subspecies rhamnosus).
A transparent bacteria of the human intestines and mouth. Faculatitive
anaerobic lactobacilli which produces lactic acid as a main product from
carbohydrates. May be effective in the treatment of certain intestional
conditions.
Lactobacillus Bulgarius
L. bulgarius is a friendly transient, but important
bacteria in the human intestineal tract. It is also a bacteria found in
yougart (along with S. thermophilus) and in cheese. It is a facultative
anaerobic lactobacillus which produces lactic acid in addition to the
benefical enzyme, lactase, which assists in the digestion of the milk sugar,
lactose.
Along with other lactic acid producing bacteria, they protect the
intestinal tract by producing an acid environment in which there is a strong
inhibition of less desirable microorganisms.
Its dramatic, anti-viral and immune-boosting powers continue to be
verified by current research. Recent studies reported in the International
Journal of Immuno-therapy, and conducted by George Halpern, M.D. Adjunct
Professor of Medicine at the Department of California, Davis, have shown that
supplementation with yougart containing L. bulgarius, stimulates
the human body to produce four times more gamma interferon than normally
produced.
Some researchers feel this strongly suggests that L bulgarius
(the very strain of beneficial microorganisms touted by Professor
Metchinikoff at the turn of the century) has the ability to boost the immune
system to supernatural levels—thus providing the body a previously
unattainable level of protection.
Lactobacillus Sporogenes
Recent scientific research points to the superiority of L.
sporogenes (also known as Bacillus coagulans), a spore forming,
non-pathogenic, gram-oxditive, aerobic lactobacillus with a high production
rate of L. positive lactic acid.
Its unique spore forming ability makes it resistant to heat, gastric
acidity, bile, harmful chemicals, radiation and antibiotics. These survival
mechanisms enable L. sporogenes to remain viable for long
periods of time without refrigeration—unlike anaerobic, non-spore forming
lactobacilli, such as acidophilus.
In addition, the rapid colonization and proliferation of L.
sporegenes enables it to control the growth of infectious organisms in
the intestines much more rapidly than do the non-spore producing lactobacilli.
The hypothesis that, implantation of these non-pathogenic, normal flora, in
large numbers, could be an effective and safe method of treating patients with
primary hyperlypidemia, was put to the test at the Department of Cardiology,
G.B. Pant Hospital, New Delhi, India. A total of 20 patients were enrolled in
the pilot clinical trial. The results of this preliminary study showed that at
the end of the three month trial period, a highly significant reduction in
total LDL cholesterol levels and a small but significant increase in HDL
cholesterol levels were recorded. Atherogenic lipid ratios ratios were also
decreased following the oral administration of L. sporagenes. No
change in serum triglycerides were noted. Spore-forming bacilli influence the
activity of enzymes involved in bile deconjugation and in cholesterol
synthesis.
L. sporogenes helps to decrease intestional absorption of
cholesterol by reducing the amount of bile salts in the gut. It is also
supportive therapy for uticaria, eczema, and strophulus infantum and as an
important adjunct during and after antibiotic therapy and chemotherapy, as
well as being an intestional aid for:
• putrefaction
• autointoxication
• dyspepsia
• anorexia
• vomiting
• flatulence
• green stools
• white diarrhea (Pseudocholera infantum).
References
1. Brochu, E., “Bacillus in Prophylaxy and Therapeutics”,
Clinical literature and references, Rosell Institute, Inc., Montreal, Canada.
2. Butler, B.C. and J.W. Beakley, (March 1960), “Bacterial Flora in
Vaginitis, American Journal of Obstetrics and Gynocology, 79.3:432-440.
3. Enby, E., Gosch, P., Sheehan., M., “Hidden Killers, the
Revoluntionary Discoveries of Professor G. Enderlein”, Sheehan Communications
(1990) and Semmelweis Institute Hasseler Steinweg9, West Germany.
4. Gorbach, S., (1982), “The Role of Intestional Flora in the Metabolism
of Drugs, Hormones and Carcinogens”, Infectious Diseases, 12, 4-30.
5. Hamdan, I.Y., and Mikolajcik, E.M., (1974), “Acidolin: An Antobotic
Produced by Lactobacillus Acidolphilus”, Journal of Antibotics 8, 631-636.
6. Harmann, J., “Immunostimulation by Bacillus Subtilis Preparations”,
g. Braun, Verlag Zeitchriften, Medizinische Bucher (1990).
7. Jameson, R.M., (1976), “The Prevention of Recurrent Urinary Tract
Infection in Women”, The Practitioner 216, 178-181.
8. Kageyama, T., TomodaT., Nakono, Y., (1983), “the Effects of
Bifidobacterium Administration in Patients with Leukemia”, Bacteria and
Microflora 3(1):29-33.
9. Mackowiak, P.A., (1982), “The Normal Microbial Flora’, New England
Journal of Medicine, 307, 83-93.
10. McGroaty, J.A. and Reid, G., (1988), “Detection of a Lactobacillus
Substance that Inhibits Escherichia Coli”, Canadian Journal Microboloigy,
34:974-978.
11. McNiel, N.T., (1984), “The Contirbution of the Large Intestine to
Energy Supplies in Man”, the American Jouranal of Clinical nutrition, 39,
338-342.
12. Mohan, R., Khalilillah, A. & m., “Prelimanary Observations on Effect
of Lactobacillus Sprogenes on Serum Lipid Levels in Hypercholesterolemic
Patients”, Dept. of Cardiology, G.B. Pant Hospital, New Dalhi, India, Journal
of Medicine, Res. (B)92, December, 1990. pp. 431-432.
13. Muhlens, K.J., “Article on the Qusetion of the So Called
Non-Specific Stimulation therapy”, Sanum-therapy, Remedy Production,
Sanum-Kehlbeck, 11/19/85.
14. Reuter, G., (1969), “Composition and Administration of Bacterial
Cultures for Therpeutic Purposes”, Arzniemittelforschjung, 19:103-109.
15. Rowland, I.R., and Grasso, P., (1975), “Degradation of Mitrosamines
by Intestional Bacteris”, Applied Muicrobiology (Jan):7-12.
16. Savage, D.C., (1980), :Colonization by and Survival of Pathogenic
Bacteria on Intestional Mucosal Surfaces”, Absorption of Microorganisims to
Surfaces, (Eds. G. Britton and K. Marshall), pp 175-206. Wiley, New York.
17. Simon, G. and Gorbach, S., (1984), “Intestional Flora in Health and
Disease”, Gastroenterology, 86:175-193.
18. Weeks, D.J., (1983), “Management of Herpes Simples with a Virostatic
Bacterial Agent”, E.E.N.T. Digest 25.
19. Wheater, D.M. et al., (1952), “Possible Identify of Lactobacillin’
With Hydrogen Peroxide Produced by Lactobacilli”, Nature 170, 623-624.
This infotmation has not been evaluated by the Food
and Drug Administration. This information and product is not intended for the
daignosis, cure, mitigation, treatment or prevention of any disease or to
encourage the abandonment of conventional therapy, but rather to serfve in a
support capacity.
|
|
|
|